GILEAD SCIENCES, INC. is 4.9x more valuable than Revolution Medicines, Inc. by market capitalization ($150.83 B vs $30.74 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | GILD | RVMD |
|---|---|---|
| Market cap | $150.83 B | $30.74 B |
| US-listed rank | #99 | #453 |
| Revenue (latest FY) | $29.44B | $0.00 |
| Net income (latest FY) | $8.51B | -$1.13B |
| Net margin | 28.9% | - |
| P/E (trailing FY) | 17.7 | - |
| SEC filings | 981 | 782 |
GILEAD SCIENCES, INC. is 4.9x more valuable than Revolution Medicines, Inc. by market capitalization ($150.83 B vs $30.74 B).
In their latest fiscal years, GILEAD SCIENCES, INC. reported $29.44B in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: GILEAD SCIENCES, INC. and Revolution Medicines, Inc., or browse the full rankings.